{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:45:59Z","timestamp":1793123159225,"version":"4.5.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jhep.2020.11.013","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T18:58:17Z","timestamp":1621796297000},"page":"S67-S81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":259,"special_numbering":"S1","title":["The microbiota in cirrhosis and its role in hepatic decompensation"],"prefix":"10.1016","volume":"75","author":[{"given":"Jonel","family":"Trebicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Macnaughtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6133-4619","authenticated-orcid":false,"given":"Debbie L.","family":"Shawcross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4928-3681","authenticated-orcid":false,"given":"Jasmohan S.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.11.013_bib1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Cirrhosis Lancet"},{"key":"10.1016\/j.jhep.2020.11.013_bib2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.11.013_bib3","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-Chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.11.013_bib4","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","article-title":"Gut microbiome and liver diseases","volume":"65","author":"Tilg","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000490262","article-title":"Gut-liver Axis links portal hypertension to acute-on-chronic liver failure","volume":"34","author":"Trebicka","year":"2018","journal-title":"Visc Med"},{"key":"10.1016\/j.jhep.2020.11.013_bib8","article-title":"PREDICT identifies precipitating events associated with clinical course of acutely decompensated cirrhosis","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib9","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.11.013_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib11","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2020.11.013_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","article-title":"Acute-on-chronic liver failure: terminology, mechanisms and management","volume":"13","author":"Sarin","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib13","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/hep.29773","article-title":"NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis","volume":"67","author":"O'Leary","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib14","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.07.019","article-title":"Serum levels of metabolites produced by intestinal microbes and lipid moieties independently associated with acute on chronic liver failure and death in patients with cirrhosis","author":"Bajaj","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.11.013_bib15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.11.013_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib17","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2020.11.013_bib19","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature14851","article-title":"Decompensated cirrhosis and microbiome interpretation","volume":"525","author":"Bajaj","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2020.11.013_bib20","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1111\/j.1572-0241.2001.04668.x","article-title":"Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis","volume":"96","author":"Bauer","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/hep.510280504","article-title":"Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis","volume":"28","author":"Chang","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000444436","article-title":"Changes of intestinal functions in liver cirrhosis","volume":"1","author":"Fukui","year":"2016","journal-title":"Inflamm Intest Dis"},{"key":"10.1016\/j.jhep.2020.11.013_bib23","first-page":"1619","article-title":"Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers","volume":"139","author":"Peng","year":"2009","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jhep.2020.11.013_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mi.2014.44","article-title":"Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway","volume":"8","author":"Park","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jhep.2020.11.013_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/gutjnl-2018-316307","article-title":"Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease","volume":"68","author":"Chu","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.06.005","article-title":"A\u00a0universal gut-microbiome-derived signature predicts cirrhosis","author":"Oh","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2020.11.013_bib28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/liv.14383","article-title":"Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease","volume":"40","author":"Addolorato","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.11.013_bib29","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/apt.15004","article-title":"Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis","volume":"48","author":"Ponziani","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.11.013_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/lt.24754","article-title":"Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis","volume":"23","author":"Bajaj","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2020.11.013_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhep.2020.11.013_bib34","doi-asserted-by":"crossref","first-page":"G929","DOI":"10.1152\/ajpgi.00315.2013","article-title":"Colonic inflammation and secondary bile acids in alcoholic cirrhosis","volume":"306","author":"Kakiyama","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.11.013_bib35","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/cr.2008.289","article-title":"FXR: a metabolic regulator and cell protector","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.jhep.2020.11.013_bib36","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2019.06.017","article-title":"FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis","volume":"71","author":"Sorribas","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","article-title":"The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats","volume":"185","author":"Verbeke","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2020.11.013_bib38","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jhep.2015.12.010","article-title":"Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats","volume":"64","author":"Ubeda","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.30349","article-title":"Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis","volume":"70","author":"Munoz","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib40","first-page":"2084","article-title":"A\u00a0syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption","volume":"88","author":"Shindo","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/gut.23.6.475","article-title":"Serum and intestinal secretory IgA in alcoholic cirrhosis of the liver","volume":"23","author":"Pelletier","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib42","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.24789","article-title":"Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense","volume":"55","author":"Teltschik","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib43","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib44","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib45","doi-asserted-by":"crossref","first-page":"32341","DOI":"10.1038\/srep32341","article-title":"Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis","volume":"6","author":"Sole","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.11.013_bib46","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jhep.2015.11.021","article-title":"Macrophage activation markers predict mortality in patients with cirrhosis without or with acute-on-chronic liver failure (ACLF)","volume":"64","author":"Gronbaek","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib47","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis","volume":"10","author":"Trebicka","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2020.11.013_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2019-320170","article-title":"Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation","author":"Monteiro","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib49","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/liv.14433","article-title":"Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure","volume":"40","author":"Praktiknjo","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.11.013_bib50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib52","doi-asserted-by":"crossref","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","article-title":"Linkage of gut microbiome with cognition in hepatic encephalopathy","volume":"302","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.11.013_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(00)00013-1","article-title":"Bacterial translocation of enteric organisms in patients with cirrhosis","volume":"34","author":"Cirera","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib55","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.22083","article-title":"Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis","volume":"47","author":"Frances","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib56","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ajg.2017.471","article-title":"Prediction of fungal infection development and their impact on survival using the NACSELD cohort","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib57","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.3389\/fmicb.2018.03166","article-title":"Disorganized gut microbiome contributed to liver cirrhosis progression: a meta-omics-based study","volume":"9","author":"Shao","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhep.2020.11.013_bib58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2020.11.013_bib59","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","article-title":"Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis","volume":"71","author":"Lang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib60","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2019.09.029","article-title":"The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease","volume":"72","author":"Chu","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31459","article-title":"Intestinal virome in patients with alcoholic hepatitis","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib62","article-title":"Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy","author":"Bajaj","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib63","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.27489","article-title":"Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib64","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/hep.25854","article-title":"Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis","volume":"56","author":"Munoz","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib65","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.29676","article-title":"Modulation of the intestinal bile acid\/farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice","volume":"67","author":"Hartmann","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib66","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","article-title":"Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis","volume":"69","author":"Brandl","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib67","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.27795","article-title":"Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults","volume":"62","author":"Shi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib68","doi-asserted-by":"crossref","first-page":"25487","DOI":"10.1038\/srep25487","article-title":"Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.11.013_bib69","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/liv.14097","article-title":"Characterization of the circulating microbiome in acute-on-chronic liver failure associated with hepatitis B","volume":"39","author":"Zhang","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.11.013_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.612","article-title":"Effect of lactulose intervention on gut microbiota and short chain fatty acid composition of C57BL\/6J mice","volume":"7","author":"Zhai","year":"2018","journal-title":"Microbiologyopen"},{"key":"10.1016\/j.jhep.2020.11.013_bib71","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/1751-7915.12370","article-title":"Revealing the combined effects of lactulose and probiotic enterococci on the swine faecal microbiota using 454 pyrosequencing","volume":"9","author":"Chae","year":"2016","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.jhep.2020.11.013_bib72","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1038\/s41598-019-50090-7","article-title":"Lactulose drives a reversible reduction and qualitative modulation of the faecal microbiota diversity in healthy dogs","volume":"9","author":"Ferreira","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.11.013_bib73","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajg.2013.08.002","article-title":"Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy","volume":"14","author":"Ziada","year":"2013","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib74","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00004836-199008000-00016","article-title":"Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients","volume":"12","author":"Riggio","year":"1990","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12876-017-0683-9","article-title":"Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration","volume":"17","author":"Sarangi","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11011-012-9303-0","article-title":"A\u00a0longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy","volume":"27","author":"Bajaj","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2020.11.013_bib77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/hep.29791","article-title":"Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib78","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2018.07.022","article-title":"Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis","volume":"17","author":"Bajaj","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hep4.1020","article-title":"Gut microbial composition can differentially regulate bile acid synthesis in humanized mice","volume":"1","author":"Kang","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2020.11.013_bib80","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/hep.30827","article-title":"Neuroinflammation in murine cirrhosis is dependent on the gut microbiome and is attenuated by fecal transplant","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib81","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib82","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40168-015-0070-0","article-title":"Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"3","author":"Weingarden","year":"2015","journal-title":"Microbiome"},{"key":"10.1016\/j.jhep.2020.11.013_bib83","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jhep.2020.01.017","article-title":"Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis","volume":"72","author":"Bajaj","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib84","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cgh.2018.05.038","article-title":"Patients with cirrhosis require more fecal microbiota capsules to cure refractory and recurrent Clostridium difficile infections","volume":"17","author":"Pringle","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib85","doi-asserted-by":"crossref","first-page":"1874570","DOI":"10.1155\/2020\/1874570","article-title":"Fecal microbiota transplantation for clostridioides difficile infection in patients with chronic liver disease","volume":"2020","author":"Meighani","year":"2020","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.12.029","article-title":"Fecal microbiota transplantation is safe and effective in patients with clostridioides difficile infection and cirrhosis","author":"Cheng","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib87","doi-asserted-by":"crossref","DOI":"10.1007\/s11901-020-00520-2","article-title":"Lessons learned from faecal microbiota transplantation in cirrhosis","author":"Hatton","year":"2020","journal-title":"Curr Hepatol Rep"},{"key":"10.1016\/j.jhep.2020.11.013_bib88","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.11.013_bib89","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gutjnl-2020-321829","article-title":"Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic","volume":"69","author":"Ianiro","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib90","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1056\/NEJMc1913670","article-title":"Donor screening for fecal microbiota transplantation","volume":"381","author":"Kassam","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.11.013_bib91","doi-asserted-by":"crossref","first-page":"G310","DOI":"10.1152\/ajpgi.00282.2013","article-title":"Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection","volume":"306","author":"Weingarden","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.11.013_bib92","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.30037","article-title":"Antibiotic-associated disruption of microbiota composition and function in cirrhosis is restored by fecal transplant","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib93","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib94","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1590-8658(01)80134-1","article-title":"Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study","volume":"33","author":"Borzio","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2020.11.013_bib95","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib96","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fernandez","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib97","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fernandez","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib98","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"Electronic address eee, clinical practice guideline panel C, panel m, representative EGB. EASL clinical practice guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib99","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib100","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.01543","article-title":"Antibiotics and the human gut microbiome: dysbiosesand accumulation of resistances","volume":"6","author":"Francino","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhep.2020.11.013_bib102","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/gutjnl-2016-313170","article-title":"Fungal dysbiosis in cirrhosis","volume":"67","author":"Bajaj","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib103","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1389557515666150722105705","article-title":"Understanding the molecular mechanisms of rifaximin in the treatment of gastrointestinal disorders--A focus on the modulation of host tissue function","volume":"16","author":"Hirota","year":"2015","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.jhep.2020.11.013_bib104","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bcp.2010.08.022","article-title":"Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells","volume":"80","author":"Mencarelli","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhep.2020.11.013_bib105","first-page":"290","article-title":"Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis","volume":"14","author":"Brigidi","year":"2002","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jhep.2020.11.013_bib106","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.3748\/wjg.v23.i25.4491","article-title":"Eubiotic properties of rifaximin: disruption of the traditional concepts in gut microbiota modulation","volume":"23","author":"Ponziani","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib107","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.gastro.2013.10.026","article-title":"Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats","volume":"146","author":"Xu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.11.013_bib108","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.11.013_bib109","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/liv.13111","article-title":"The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-alpha","volume":"36","author":"Orr","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.11.013_bib110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/flgastro-2016-100792","article-title":"The impact of rifaximin-alpha on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)","volume":"8","author":"Hudson","year":"2017","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib111","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1038\/ctg.2016.44","article-title":"Rifaximin exerts beneficial effects independent of its ability to alter microbiota composition","volume":"7","author":"Kang","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib112","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/apt.14361","article-title":"Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis","volume":"46","author":"Goel","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.11.013_bib113","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/MEG.0000000000000967","article-title":"Long-term rifaximin therapy as a primary prevention of hepatorenal syndrome","volume":"29","author":"Ibrahim","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib114","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/apt.15326","article-title":"Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all-cause admissions in patients on the liver transplant waiting list","volume":"50","author":"Salehi","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.11.013_bib115","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/lt.25633","article-title":"Impact of rifaximin therapy on ischemia\/reperfusion injury in liver transplantation: a propensity score-matched analysis","volume":"25","author":"Ito","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2020.11.013_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186120","article-title":"Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients","volume":"12","author":"Chang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.11.013_bib117","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hep.24751","article-title":"Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis","volume":"55","author":"Kalambokis","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060042","article-title":"Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy","volume":"8","author":"Bajaj","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.11.013_bib119","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jgh.13852","article-title":"Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: a randomized trial","volume":"33","author":"Kimer","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib120","first-page":"665","article-title":"Does low-dose rifaximin ameliorate endotoxemia in patients with cirrhosis: a prospective study","volume":"16","author":"Zeng","year":"2015","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.jhep.2020.11.013_bib121","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-018-04450-y","article-title":"Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver","volume":"9","author":"Hegde","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2020.11.013_bib122","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/hep.24273","article-title":"AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct-ligated rats","volume":"53","author":"Bosoi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib123","first-page":"CD012334","article-title":"Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis","volume":"6","author":"Zacharias","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhep.2020.11.013_bib124","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1021\/bm200982g","article-title":"Activation-dependent adsorption of cytokines and toxins related to liver failure to carbon beads","volume":"12","author":"Tripisciano","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jhep.2020.11.013_bib125","doi-asserted-by":"crossref","first-page":"S463","DOI":"10.1016\/S0168-8278(18)31173-5","article-title":"Characterization of the protective effects of Yaq-001 on organ injury in cirrhosis","volume":"68","author":"De Chiara","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(15)30110-0","article-title":"Oral therapy with non-absorbable carbons of controlled porosity (Yaq-001) selectively modulates stool microbiome and its function and this is associated with restoration of immune function and inflammasome activation","volume":"62","author":"Macnaughtan","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib127","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1136\/gutjnl-2017-314553","article-title":"Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(-\/-) mice by modulating composition, signalling and excretion of faecal bile acids","volume":"67","author":"Fuchs","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8060925","article-title":"Bile acid sequestrant, sevelamer ameliorates hepatic fibrosis with reduced overload of endogenous lipopolysaccharide in experimental nonalcoholic steatohepatitis","volume":"8","author":"Tsuji","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.jhep.2020.11.013_bib129","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1074\/jbc.RA119.011913","article-title":"Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice","volume":"295","author":"Takahashi","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2020.11.013_bib130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fnut.2020.00079","article-title":"A\u00a0guide to diet-microbiome study design","volume":"7","author":"Johnson","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.jhep.2020.11.013_bib131","article-title":"Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy","author":"Saboo","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib132","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1096\/fj.14-259515","article-title":"Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice","volume":"29","author":"Mazagova","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2020.11.013_bib133","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1101\/gad.284091.116","article-title":"Metabolites: messengers between the microbiota and the immune system","volume":"30","author":"Levy","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2020.11.013_bib134","article-title":"Modulation of the intestinal bile acid-FXR-FGF15 axis improves alcoholic liver disease in mice","author":"Hartmann","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib135","doi-asserted-by":"crossref","first-page":"12000","DOI":"10.1038\/s41598-019-48352-5","article-title":"Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis","volume":"9","author":"Horvath","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.11.013_bib136","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41395-018-0085-9","article-title":"Proton pump inhibitor initiation and withdrawal affects gut microbiota and readmission risk in cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib137","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/hep.28330","article-title":"Antibiotic prophylaxis in cirrhosis: good and bad","volume":"63","author":"Fernandez","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib138","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2020.11.013_bib139","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41467-020-14676-4","article-title":"Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment","volume":"11","author":"Liu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2020.11.013_bib140","doi-asserted-by":"crossref","first-page":"G824","DOI":"10.1152\/ajpgi.00230.2018","article-title":"Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis","volume":"315","author":"Bajaj","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.11.013_bib141","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/138920110790725410","article-title":"Phage therapy pharmacology","volume":"11","author":"Abedon","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jhep.2020.11.013_bib142","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/hep.27819","article-title":"Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy","volume":"62","author":"Bajaj","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib143","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-14-40","article-title":"Changes in gut bacterial populations and their translocation into liver\u00a0and ascites in alcoholic liver cirrhotics","volume":"14","author":"Tuomisto","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib144","doi-asserted-by":"crossref","first-page":"25001","DOI":"10.1038\/srep25001","article-title":"Alteration of the serum microbiome composition in cirrhotic patients with ascites","volume":"6","author":"Santiago","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.11.013_bib145","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/gutjnl-2018-316227","article-title":"Circulating microbiome in blood of different circulatory compartments","volume":"68","author":"Schierwagen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.11.013_bib146","article-title":"Influence of the biliary system on biliary bacteria revealed by bacterial communities of the human biliary and upper digestive tracts","volume":"11","author":"Ye","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.11.013_bib147","article-title":"A\u00a0randomized clinical trial of fecal microbiota transplant for alcohol use disorder","author":"Bajaj","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib148","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.013_bib149","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12664-018-0859-4","article-title":"Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis","volume":"37","author":"Philips","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hep.28121","article-title":"Fecal microbiota transplantation in the management of hepatic encephalopathy","volume":"63","author":"Kao","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib151","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.013_bib152","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s12664-018-0906-1","article-title":"Preliminary experience with single fecal microbiota transplant for treatment of recurrent overt hepatic encephalopathy-A case series","volume":"37","author":"Mehta","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.013_bib153","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133410","article-title":"Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis","volume":"4","author":"Bajaj","year":"2019","journal-title":"JCI Insight"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820337661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820337661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:43:56Z","timestamp":1759175036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820337661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":153,"alternative-id":["S0168827820337661"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.013","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The microbiota in cirrhosis and its role in hepatic decompensation","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}